Evaluating Effectiveness and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia in (CML-CP) without Optimal Response (Warning, Failure) to Imatinib or/and DasatinibLi Weiming,Yanli Zhang,Zhiwei Wu,Qin Wen,Qing Leng, Shuting Wu,Xiaodong Wang,Shiming Chen,Guolin Yuan,Sixuan Qian,Suning Chen,Daozi Jiang, Lianjun Diao,Zhenfang Xi, Hui Wu,Hui Sun,Lijie Yang, Hongjuan Wang,Xuefang Zhang,Yanli Xu,Xielan Zhao,Na Xu,Li Meng,Zunmin Zhu,Youfang Zhao, Meifang Su,Zhuangzhi Yang, Chuancai Liu,Danlei Han,Yu HuBLOOD（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
